A 
15,660
-1.57%
Close of 9 Nov 2026, in KRW
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in KRW, from our data supplier.
Revenue
₩4.64bn
FY2020FY2025
Net income
−₩9.72bn
FY2020FY2025
Free cash flow
−₩8.20bn
FY2020FY2025
Shareholders' equity
₩32.63bn
FY2020FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Revenue | ₩4.64bn | ₩4.21bn | ₩5.15bn | ₩2.18bn | ₩813.9m | ₩104.5m |
| Gross profit | ₩2.61bn | ₩2.51bn | ₩4.05bn | ₩1.00bn | ₩249.8m | −₩37.0m |
| Research and development | ₩2.72bn | ₩2.43bn | ₩1.19bn | ₩1.88bn | ₩1.07bn | — |
| Operating income | −₩10.28bn | −₩10.84bn | −₩6.50bn | −₩7.10bn | −₩4.83bn | −₩2.39bn |
| Net income | −₩9.72bn | −₩10.01bn | −₩9.24bn | −₩6.80bn | −₩24.09bn | −₩7.43bn |
| Diluted earnings per share | -637.17 | -667.46 | -659.22 | -485.00 | -1,719.16 | -530.45 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Total assets | ₩37.03bn | ₩43.88bn | ₩21.32bn | ₩16.46bn | ₩22.20bn | ₩7.85bn |
| Cash and short-term investments | — | — | ₩14.60bn | ₩10.25bn | ₩17.12bn | ₩5.26bn |
| Total liabilities | ₩4.41bn | ₩3.55bn | ₩12.64bn | ₩36.24bn | ₩36.07bn | ₩15.92bn |
| Debt | — | — | ₩10.28bn | ₩9.26bn | ₩8.74bn | ₩7.69bn |
| Shareholders' equity | ₩32.63bn | ₩40.33bn | ₩8.68bn | −₩19.79bn | −₩13.86bn | −₩8.07bn |
| Shares outstanding | 15m | 15m | 14m | 14m | 14m | 14m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Cash from operations | −₩7.22bn | −₩7.23bn | −₩4.35bn | −₩5.76bn | −₩3.76bn | −₩1.84bn |
| Capital spending | −₩980.5m | −₩2.12bn | −₩1.21bn | −₩919.3m | −₩1.81bn | −₩306.2m |
| Free cash flow | −₩8.20bn | −₩9.34bn | −₩5.56bn | −₩6.68bn | −₩5.57bn | −₩2.15bn |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩788.3m | ₩507.1m | ₩1.27bn | ₩805.9m | ₩1.49bn | ₩1.07bn | ₩848.6m | ₩945.5m |
| Gross profit | ₩460.7m | ₩322.4m | ₩436.2m | ₩544.9m | ₩938.1m | ₩692.1m | ₩835.3m | ₩633.1m |
| Operating income | −₩3.49bn | −₩2.68bn | −₩2.77bn | −₩2.84bn | −₩2.18bn | −₩2.49bn | −₩3.54bn | −₩2.39bn |
| Net income | −₩1.14bn | −₩2.53bn | −₩2.63bn | −₩2.68bn | −₩1.97bn | −₩2.43bn | −₩3.35bn | −₩2.17bn |
| Diluted earnings per share | -74.70 | -165.67 | -172.35 | -176.68 | -129.99 | -162.16 | -223.42 | -145.09 |
| Cash from operations | −₩2.38bn | −₩2.03bn | −₩1.60bn | −₩1.61bn | −₩1.76bn | −₩2.25bn | −₩7.23bn | −₩6.02bn |
| Capital spending | −₩124.0m | −₩51.0m | −₩241.0m | −₩77.0m | −₩37.0m | −₩623.0m | −₩2.12bn | −₩1.97bn |
| Free cash flow | −₩2.51bn | −₩2.08bn | −₩1.84bn | −₩1.69bn | −₩1.79bn | −₩2.88bn | −₩9.34bn | −₩7.98bn |
| Total assets | ₩36.27bn | ₩35.36bn | ₩37.03bn | ₩39.52bn | ₩42.06bn | ₩43.11bn | ₩43.88bn | ₩46.22bn |
| Cash and short-term investments | — | — | — | — | — | ₩29.13bn | ₩31.69bn | ₩32.47bn |
| Debt | — | — | — | — | — | ₩961.5m | ₩202.6m | ₩249.6m |
| Shareholders' equity | ₩30.98bn | ₩30.51bn | ₩32.63bn | ₩34.69bn | ₩37.19bn | ₩38.08bn | ₩40.33bn | ₩43.34bn |
Financial ratios
Data as of 1 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Gross margin | 56.3% | 59.6% | 78.6% | 45.9% | 30.7% |
| Operating margin | -221.4% | -257.5% | -126.2% | -325.1% | -593.3% |
| Net margin | -209.3% | -237.6% | -179.5% | -311.2% | -2960.2% |
| Return on equity | -29.8% | -24.8% | -106.5% | 34.4% | 173.8% |
| Return on assets | -26.2% | -22.8% | -43.3% | -41.3% | -108.5% |
| Revenue growth | 10.2% | -18.2% | 135.6% | 168.4% | — |
| Earnings growth | -2.9% | 8.3% | 35.9% | -71.8% | — |
| Current ratio | 23.43x | 30.22x | 1.56x | 0.36x | 0.52x |
| Debt to equity | — | — | 0.00x | 0.00x | 0.00x |
| Equity ratio | 88.1% | 91.9% | 40.7% | -120.2% | -62.4% |
| Interest coverage | -79.88x | -141.38x | -10.59x | -8.80x | -6.15x |
| R&D as a share of sales | 58.6% | 57.7% | 23.2% | 85.9% | 131.6% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 28.6% | 113.6% | — |
| Operating income | 13.1% | 33.8% | — |
| Net income | 12.6% | 5.5% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 57.8% | 62.8% | 60.7% | — |
| Operating margin | -238.6% | -214.5% | -245.2% | — |
| Net margin | -222.8% | -221.0% | -393.5% | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | |
|---|---|---|
| Price to earnings | -48.1 | -34.5 |
| Price to sales | 100.7 | 82.1 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.